Tandem Diabetes Care has filed a patent for apparatuses and methods to enhance user interactions with touchscreens of ambulatory medical devices. The invention includes an operating mode that records user interactions and device parameters, allowing clinicians to review and analyze patient performance. The results can be used to improve patient-device interaction. GlobalData’s report on Tandem Diabetes Care gives a 360-degree view of the company including its patenting strategy. Buy the report here.
According to GlobalData’s company profile on Tandem Diabetes Care, wearable drug delivery devices was a key innovation area identified from patents. Tandem Diabetes Care's grant share as of September 2023 was 48%. Grant share is based on the ratio of number of grants to total number of patents.
Training users of ambulatory medical devices to improve interactions
A recently filed patent (Publication Number: US20230290474A1) describes an ambulatory infusion pump system designed to improve the treatment of diabetes. The system includes an ambulatory infusion pump that delivers medication to the user and a communications interface that receives glucose level data from the user. The system also features at least one processor that analyzes parameters related to the programming and operation of the pump, as well as the user's glucose level data, using automated analysis software. Based on this analysis, the software identifies trends in the user's operation of the device and provides user-specific recommendations for improving treatment.
The system's processor is configured to analyze insulin dosages delivered by the pump to the user. Additionally, the automated analysis software can analyze data related to the user's physical state to identify trends. The glucose level data is received from a glucose monitor, and the system may include a display, such as a smartphone, to provide the user-specific recommendations.
Furthermore, the system includes a computing device on which the automated analysis software resides. The processor can transfer the parameters and glucose level data to the computing device for further analysis. The identified trends in user operation may include errors where the user's operation does not match caregiver instructions or difficulties where the user's operation deviates significantly from the optimal path for operating the pump. The user-specific recommendations may involve changing the settings of the ambulatory infusion pump.
Another embodiment of the ambulatory infusion pump system includes a user interface for controlling the pump, a memory for storing user input and pump parameters, and at least one processor. This processor detects user input, causes the pump to deliver medication based on the input, and stores the input and parameters in the memory. The processor then analyzes the stored data using analysis software to identify areas where the user can modify the pump's operation. Based on this analysis, the system provides recommendations to the user for changing pump settings to improve operation.
The user interface can be part of the pump itself or a separate remote device, such as a smartphone. The analysis software may reside on a computing device, and the processor can receive recommendations from this device. The memory may be part of the pump, and the analysis software can identify areas for modification by comparing user input and pump parameters to caregiver instructions or the optimal path for operation.
Overall, this patent describes an ambulatory infusion pump system that utilizes automated analysis software to analyze user data and provide personalized recommendations for improving diabetes treatment.